This text investigates the biological, clinical, and behavioral mechanisms underlying the high prevalence of Alzheimer disease in individuals with Down Syndrome. The authors, A. J. Holland, H. Karlinsky, and J. M. Berg, synthesize existing clinical data and genetic research to evaluate why Down Syndrome serves as a significant risk factor for early-onset dementia. The book provides a structured framework for understanding the neuropathological overlap between these two conditions while offering practical guidance for clinical management.

Medical professionals and researchers frequently cite this work as a foundational text for understanding the specific neurodegenerative risks associated with Down Syndrome. Experts highlight the clarity of the clinical recommendations as particularly useful for practitioners managing adult patients.